Product Details:
| Composition | Erdafitinib tablets |
| Strength | 4 mg |
| Brand | Erdafixen 4 mg tablets |
| Tablets per Pack | 28 Tablets |
| Brand Name | Erdafixen 4 mg tablets |
| Usage | Blood cancer |
| Packaging Size | 28 tablets |
| Form | Tablet |
| Pack Type | Bottle |
| Manufacturer | Everest pharma |
| Packaging Type | Bottle |
| Treatment | Mantle-cell lymphoma |
| Usage / Application | Resale / B2B |
| Country of Origin | India |
Erdafitinib 4mg tablets (e.g., Erdanib, Balversa) are a kinase inhibitor used to treat adults with advanced or metastatic urothelial carcinoma (bladder cancer) possessing specific FGFR3 or FGFR2 genetic alterations. It is prescribed for patients whose cancer has progressed following platinum-containing chemotherapy